Please login to the form below

Not currently logged in
Email:
Password:

non-adherence

This page shows the latest non-adherence news and features for those working in and with pharma, biotech and healthcare.

Behaviour change needs a quantified approach

Behaviour change needs a quantified approach

Non-adherence to treatment currently ranges from 25% to an eye-watering 78%.

Latest news

  • Assisting adherence Assisting adherence

    Helping transplant patients. A particularly interesting case for medication non-adherence exists among transplant patients. ... EFPIA estimates non-adherence causes 200, 000 premature deaths every year in the EU.

  • Things can only get better Things can only get better

    tools to support patients, the incidence of non-adherence remains stuck where it was in the 90s. ... Chris Edmonds, managing director, emotive, thinks this is essential if we're to shift the needle of non-adherence.

  • Changing behaviours begins at home Changing behaviours begins at home

    For example, research shows that non-adherence to medicines is often related to patients' beliefs about their illness and treatment.

  • Responding to non-adherence Responding to non-adherence

    Non-adherence costs the EU approximately 125bn and nearly 200, 000 lives every year. ... Non-adherence is a global epidemic. Collaborative solutions. The battle to improve adherence is a collective responsibility.

  • The behavioural science of adherence The behavioural science of adherence

    In order to tackle the problem, it's necessary to understand the varying types and causes of non-adherence. ... Interventions should then be tailored accordingly. According to Prof Weinman, there are two types of non-adherence: unintentional

More from news
Approximately 0 fully matching, plus 32 partially matching documents found.

Latest Intelligence

  • Key considerations for disease- modifying Parkinson’s disease trials Key considerations for disease- modifying Parkinson’s disease trials

    consequence. Take special measures to ensure adherence to the investigation product for non- injectable therapies.This is mandatory for all long-lasting prophylactic treatments. ... adherence with the subject and caregiver; c) a Patient Workbook that

  • How behavioural design is transforming the role and impact of life sciences in healthcare How behavioural design is transforming the role and impact of life sciences in healthcare

    Non-adherence, for example, costs up to US$290m in the US alone. ... i] Rachel Louise Cutler et al., Economic impact of medication non-adherence by disease groups: a systematic review (BMJ Journals: Volume 8, Issue 1, 2017).

  • A new era of smart pharma A new era of smart pharma

    According to a systematic review of 39 studies, published in Clinical Psychology in 2002, a mean rate of medication non-adherence in schizophrenia sufferers is 41%, one of the highest of ... Furthermore, given the serious negative effects of

  • Six degrees of participation Six degrees of participation

    As we’ve established, not all patients want to ‘participate’. But by meeting them halfway - and developing tools that speak their language - we can reduce the barriers to non-adherence. ... patients. These are patient-centred, not brand-led,

  • The rise of real-world evidence The rise of real-world evidence

    real world, where comorbidities, non-adherence and other issues controlled for in trials affect outcomes. ... approval. When combined with the rising demand for non-RCT data from payers and providers, the evolution of regulatory attitudes will establish

More from intelligence
Approximately 1 fully matching, plus 24 partially matching documents found.

Latest from PMHub

  • Why patient education isn’t simple

    At this point, medication adherence is likely to increase, complications reduce, and patient progress enhance. . ... This relationship can enable not only patient activation but patient participation in the decision-making process around their treatment

  • Empowered patients improve outcomes

    This white paper co-authored by our own Caroline Benson and Guy Yeoman, MediPaCe, discusses why non-adherence is occurring, how patients’ can be better engaged with their conditions and treatments ... Non-adherence to medication is not a new global

  • Download the Patient Support Programme Guidebook

    With the rise of specialty medicines, the staggering cost of non-adherence and the demand for value from all stakeholders, it’s no surprise that patient support programmes are becoming ‘cost

  • Designing patient education programmes for MOOCs

    patients, and less non-adherence.

  • Where is health behaviour change heading?

    According to the Aston Medication Adherence Study of 2013,   non-adherence costs the NHS £500 million per year  – and that’s a lot of money that could be used to save ... If erroneous health behaviour is to blame for non-adherence, then health

More from PMHub
Approximately 0 fully matching, plus 19 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Ashfield

Ashfield, part of UDG Healthcare plc, is a global leader in commercialisation services for the healthcare industry. We partner with...

Latest intelligence

Report: Achieving launch excellence in the challenging healthcare markets of today
Our in-depth report is based on original data and expert interviews, which coupled with our own experience, ensures we give you the best recommendations for achieving launch success in challenging...
What is blockchain and why should i care - Richard Springham
Four Health - Emerging Technologies The power of blockchain lies in the fact it can prove that a unique event occurred at a certain time with out the need to...
NHS medicines optimisation milestone
Steve How, Paul Midgley and Oli Hudson, of the Wilmington Healthcare Consulting Team, explore the implications of Adalimumab’s recent European patent expiry...

Infographics